Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 16, 2026

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Multi-species prostate implant treatment plans incorporating 192Ir and 125I using a Greedy Heuristic based 3D

V Chaswal1, S Yoo, B R Thomadsen

  • 1Department of Engineering Physics, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.

Medical Physics
|March 29, 2007
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026

Combining Iodine-125 (125I) and Iridium-192 (192Ir) seeds in prostate brachytherapy improves dose uniformity and reduces the number of seeds and needles. This multi-species approach offers a more efficient and potentially safer interstitial implant treatment.

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Nuclear Medicine

Background:

  • Interstitial brachytherapy aims for uniform dose delivery while sparing organs at risk.
  • Minimizing radioactive sources and implantation needles is crucial for patient safety and treatment efficiency.
  • Current prostate brachytherapy often utilizes single-isotope seeds, primarily Iodine-125 (125I).

Purpose of the Study:

  • To investigate the efficacy of a multi-species source arrangement using both Iridium-192 (192Ir) and Iodine-125 (125I) seeds for interstitial prostate brachytherapy.
  • To evaluate the impact of mixing 192Ir seeds with 125I seeds on dose distribution, organ sparing, and treatment parameters.
  • To assess the influence of different 192Ir seed activities on treatment uniformity and efficiency.

Main Methods:

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

Related Experiment Videos

Last Updated: Jul 16, 2026

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

  • A Greedy Heuristic optimization algorithm utilizing an "adjoint ratio" was employed to rank source positions.
  • Three treatment cases were simulated: Case I (125I alone), Case II (0.12 mCi 192Ir + 125I), and Case III (0.25 mCi 192Ir + 125I).
  • Dose exposure to the urethra, central prostate, rectum, and normal tissues was analyzed, alongside the number of seeds and needles required.

Main Results:

  • Both multi-species cases (II and III) demonstrated reduced radiation exposure to the urethra and central prostate compared to the base case (I).
  • Case III showed a greater increase in rectal and normal tissue exposure than Case II, attributed to the slower dose falloff of 192Ir.
  • Multi-species implants significantly decreased the total number of seeds and needles, with Case III requiring fewer than Case II.
  • Increasing the number of 0.12 mCi 192Ir seeds in multi-species implants led to improved dose uniformity.
  • Acceptable treatment plans with enhanced uniformity were achieved for various prostate sizes using 0.12 mCi 192Ir and 0.4 mCi 125I seeds.

Conclusions:

  • The combination of 192Ir and 125I seeds in interstitial prostate brachytherapy offers advantages in dose uniformity and reduction of implant material.
  • Careful selection of 192Ir seed activity and number is essential to balance improved uniformity with potential increases in dose to surrounding normal tissues.
  • Multi-species brachytherapy presents a viable strategy for optimizing prostate cancer treatment, particularly for achieving better dose conformity and efficiency.